245 related articles for article (PubMed ID: 26648013)
1. Inhibitor of DNA binding 4 functions as a tumor suppressor and is targetable by 5-aza-2'-deoxycytosine with potential therapeutic significance in Burkitt's lymphoma.
Gao XZ; Zhao WG; Wang GN; Cui MY; Zhang YR; Li WC
Mol Med Rep; 2016 Feb; 13(2):1269-74. PubMed ID: 26648013
[TBL] [Abstract][Full Text] [Related]
2. [Effect of 5-Aza-CdR on biological activity and inhibitor of DNA binding 4 gene expression in human erythroleukemia cell line K562].
Wang LF; Huang S; Huang C; Li CR; Li DJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1388-92. PubMed ID: 22169289
[TBL] [Abstract][Full Text] [Related]
3. [Methylation of Id4 gene and inhibitive effect of arsenic trioxide on it in Raji cells].
Qu F; Zhao CH; Diao YQ; Zhu XL; Chen J; Li M; Liu CP; Jiang L; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2010 Dec; 31(12):821-5. PubMed ID: 21223739
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.
Carey JP; Asirvatham AJ; Galm O; Ghogomu TA; Chaudhary J
BMC Cancer; 2009 Jun; 9():173. PubMed ID: 19500415
[TBL] [Abstract][Full Text] [Related]
5. [The cloning of human Smac gene and its pro-apoptotic effect on Burkitt's lymphoma cells].
Lu C; Wu SH; Chen JQ; Zhao F; Chi X; Pan XQ; Fei L; Guo M; Huang SM; Guo XR; Chen RH
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):503-6. PubMed ID: 16083549
[TBL] [Abstract][Full Text] [Related]
6. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
7. Association between lymphoma prognosis and aberrant methylation of ID4 and ZO-1 in bone marrow and paraffin-embedded lymphoma tissues of treatment-naive patients.
Cen J; Shen J; Wang X; Kang H; Wang L; Sun L; Li Y; Yu L
Oncol Rep; 2013 Jul; 30(1):455-61. PubMed ID: 23670122
[TBL] [Abstract][Full Text] [Related]
8. [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].
Noetzel E; Veeck J; Horn F; Hartmann A; Knüchel R; Dahl E
Pathologe; 2008 Nov; 29 Suppl 2():319-27. PubMed ID: 18807039
[TBL] [Abstract][Full Text] [Related]
9. Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cells.
Kobayashi M; Nakamura S; Shibata K; Sahara N; Shigeno K; Shinjo K; Naito K; Ohnishi K
Eur J Haematol; 2005 Sep; 75(3):212-20. PubMed ID: 16104877
[TBL] [Abstract][Full Text] [Related]
10. [Effect of 5-aza-2'-deoxycytidine on growth and methylation of RUNX3 gene in human pancreatic cancer cell line MiaPaca2].
Han X; Tan ZJ; Guo RD; Li ZJ; Wang YL
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):17-21. PubMed ID: 23648294
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer.
Sharma P; Chinaranagari S; Patel D; Carey J; Chaudhary J
Cancer Med; 2012 Oct; 1(2):176-86. PubMed ID: 23342267
[TBL] [Abstract][Full Text] [Related]
12. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
[TBL] [Abstract][Full Text] [Related]
13. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C
Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362
[TBL] [Abstract][Full Text] [Related]
14. MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells.
Mazzoccoli L; Robaina MC; Apa AG; Bonamino M; Pinto LW; Queiroga E; Bacchi CE; Klumb CE
J Cancer Res Clin Oncol; 2018 Mar; 144(3):483-497. PubMed ID: 29318382
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer.
Noetzel E; Veeck J; Niederacher D; Galm O; Horn F; Hartmann A; Knüchel R; Dahl E
BMC Cancer; 2008 May; 8():154. PubMed ID: 18513385
[TBL] [Abstract][Full Text] [Related]
16. Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma.
Murray PG; Qiu GH; Fu L; Waites ER; Srivastava G; Heys D; Agathanggelou A; Latif F; Grundy RG; Mann JR; Starczynski J; Crocker J; Parkes SE; Ambinder RF; Young LS; Tao Q
Oncogene; 2004 Feb; 23(6):1326-31. PubMed ID: 14961078
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma.
Chan AS; Tsui WY; Chen X; Chu KM; Chan TL; Chan AS; Li R; So S; Yuen ST; Leung SY
Oncogene; 2003 Oct; 22(44):6946-53. PubMed ID: 14534543
[TBL] [Abstract][Full Text] [Related]
18. [SHP-1 gene's methylation status of Daudi lymphoma cell and the demethylation effect of 5-aza-2'-deoxycytidine].
Fang JC; Su ZL; Qiu G; He D; Feng ZY; Zhu MF; Li L; He XL
Zhonghua Xue Ye Xue Za Zhi; 2006 Oct; 27(10):670-4. PubMed ID: 17343198
[TBL] [Abstract][Full Text] [Related]
19. [Effects of mTOR Inhibitor Rapamycin on Burkitt's Lymphoma Cells].
Zhou LH; Zhu XP; Xiao HF; Xin PL; Li CT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1397-1405. PubMed ID: 29070114
[TBL] [Abstract][Full Text] [Related]
20. Frequent DNA methylation but not mutation of the ID4 gene in malignant lymphoma.
Hagiwara K; Nagai H; Li Y; Ohashi H; Hotta T; Saito H
J Clin Exp Hematop; 2007 Apr; 47(1):15-8. PubMed ID: 17510533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
